Donna Cabral - Lilly

Donna Cabral-Lilly has extensive experience in pharmaceutical development and manufacturing, with a focus on CMC program strategy. Donna has held various leadership roles in companies such as Onxeo S.A., ORYN THERAPEUTICS, LLC, and Origin Biosciences. Donna's background includes a PhD in biochemistry and biophysics from Boston University, as well as a postdoctoral fellowship in Structural Biology from Brandeis University.